• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Corvus Pharma Com (NQ: CRVS )

    9.100 +0.260 (+2.94%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Corvus Pharma Com

    < Previous 1 2 3 4 5 Next >
    Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
    Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
    Via Benzinga
    Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 10, 2022
    Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
    Via Benzinga
    Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022
    Event will focus on CPI-818 (ITK inhibitor) clinical development and will take place at 4:30 pm ET / 1:30 pm PT 
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Corvus Pharmaceuticals to Present Updated CPI-818 (ITK Inhibitor) Data at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
    Company to host conference call and webcast on December 12, 2022 at 4:30 pm ET / 1:30 pm PT 
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Earnings Preview For Corvus Pharmaceuticals
    Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 3, 2022
    Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT 
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
    From Corvus Pharmaceuticals, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
    Upgrades 
    Via Benzinga
    10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners
    In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl. 
    Via Talk Markets
    Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer
    Via Benzinga
    Corvus Pharmaceuticals: Q2 Earnings Insights
      Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Recap: Corvus Pharmaceuticals Q4 Earnings
    Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    A Preview Of Corvus Pharmaceuticals's Earnings
    Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.... 
    Via Benzinga
    The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus... 
    Via Benzinga
    This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
    Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
    Via Benzinga
    Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
    Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers GBS (NASDAQ:GBS 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
    Via Benzinga
    The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
    Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3... 
    Via Benzinga
    The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million
    Fosun Pharma announced a $628 million deal to acquire a 73% stake in Chengdu Antejin Biotech, a vaccine company. Fosun paid $174 million to nine Antejin shareholders and it contributed its own... 
    Via Talk Markets
    The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
    Via Benzinga
    The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
    Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity... 
    Via Benzinga
    51 Biggest Movers From Yesterday
    Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Regencell Bioscience (NASDAQ:RGC)... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.